Randy Yeh - Concepedia

Author

Randy Yeh

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Abraham J Wu, Karen L. Bell, R. Yeh, Raina Carter, Randall Griffith, Randy Yeh

112

Publications

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Columbia University Irving Medical Center NewYork–Presbyterian Hospital New York Hospital Queens Columbia University

About

Randy Yeh is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, health sciences, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	807
2	Health Sciences	9	9	639
3	Immunology	3	3	238
4	Pathology	2	2	84
5	Engineering	1	1	11

Randy Yeh

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study C. Jillian Tsai, Jonathan T. Yang, Narek Shaverdian, The Lancet Adaptive RadiotherapyRadiation TherapyMedicineOligoprogressive Breast CancerBreast Cancer	2023	214
Prolonged red cell storage before transfusion increases extravascular hemolysis Francesca Rapido, Gary M. Brittenham, Sheila Bandyopadhyay, Journal of Clinical Investigation	2016	197
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer Justin Jee, Emily S. Lebow, Randy Yeh, Nature Medicine Tumor Dna-guided TherapyOverall SurvivalMedicineBronchial NeoplasmCancer Treatment	2022	170
Diagnostic Performance of 4D CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism Randy Yeh, Donovan Tay, Gaia Tabacco, Radiology	2019	136
Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics Romain‐David Seban, John S. Nemer, Aurélien Marabelle, European Journal of Nuclear Medicine and Molecular Imaging Cancer ImmunosurveillanceAnti-pd1 ImmunotherapyMedicineBiomarker TargetMelanoma	2019	123
Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion Richard O. Francis, Angelo D’Alessandro, Andrew Eisenberger, Journal of Clinical Investigation	2020	108
Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4 Romain‐David Seban, Antoine Moya‐Plana, Lara Antonios, European Journal of Nuclear Medicine and Molecular Imaging Cancer ImmunosurveillanceMedicineImmune Checkpoint InhibitorsMelanomaImmunology	2020	73
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted <sup>89</sup>Zr-Pertuzumab PET/CT Gary A. Ulaner, Jorge A. Carrasquillo, Christopher C. Riedl, Radiology	2020	68
Consolidative Use of Radiotherapy to Block (CURB) Oligoprogression ― Interim Analysis of the First Randomized Study of Stereotactic Body Radiotherapy in Patients With Oligoprogressive Metastatic Cancers of the Lung and Breast C. Jillian Tsai, Jie Yang, David Guttmann, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineCancer TherapeuticsRadiation TherapyOligoprogressive Metastatic CancersTreatment Verification	2021	67
18Fluorine sodium fluoride positron emission tomography, a potential biomarker of transthyretin cardiac amyloidosis Rachelle Morgenstern, Randy Yeh, Adam Castaño, Journal of Nuclear Cardiology Positron Emission TomographyAlzheimer's DiseasePotential BiomarkerPathologyMedicine	2017	65

Page 1